Skip to main content

Squarepoint Ops LLC

SEC CIK
0001642575
Latest filing
Aug 14, 2026

ENGN holding history

enGene Therapeutics Inc. in every 13F filed by Squarepoint Ops LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ENGN overviewAll 13F holders of ENGNFull Q2 2026 holdings

Shares (Q2 2026)
215,381
Value
$372.6K
% of portfolio
<0.1%
Quarters held
2
Since Q1 2026
Holdings of ENGN by Squarepoint Ops LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026215,381$372.6K<0.1%+166,482+340.5%AddedHolders
Q1 202648,899$333.0K<0.1%+48,899NewHolders